Relevium Medical is a biopharmaceutical company dedicated to addressing chronic pain through innovative treatment solutions. Their approach integrates natural biopolymers with pharmacologically active agents, allowing for the development of tailored treatments that target various chronic pain conditions. This pioneering methodology has led to the creation of a range of novel hydrogel products that demonstrate superior efficacy compared to existing treatments. The company emphasizes the importance of multimodal treatment strategies, which not only address pain but also other disease-specific symptoms, thereby improving overall patient outcomes.

The company's product pipeline includes several advanced hydrogel candidates designed for specific applications. For instance, RM-010 is an injectable hydrogel that provides long-lasting pain relief for osteoarthritis, while RM-020 serves as a gel replacement for damaged bladder lining and alleviates overactive pain-sensing nerves in interstitial cystitis. Additionally, RM-030 is formulated as a broad-spectrum antimicrobial gel for trauma wound infections, offering both pain reduction and infection prevention. RM-040 is another hydrogel treatment aimed at post-surgical pain relief, significantly reducing the need for opioid medications. Through these innovative products, Relevium Medical is committed to enhancing the quality of life for individuals suffering from chronic pain.

Ireland

Relevium Medical are a biopharmaceutical company with locations in Ireland and the US. We aspire to improve the lives of people with debilitating chronic pain conditions through creating superior treatments.

Relevium Medical

Company Details